BECTON, DICKINSON AND COMPANY Empresa Becton, Dickinson and Company Wiener Boerse
Acciones
BDX
US0758871091
Equipo médico, suministros y distribución
|
Precio de cierre
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 218,5 EUR | -0,36 % |
|
+0,60 % | -0,68 % |
Resumen de negocios
- equipos médicos (73,5%): instrumental quirúrgico, productos para cuidados urológicos, sistemas farmacéuticos, etc;
- materiales de diagnóstico (18,7%): sistemas automatizados para análisis de sangre, detección de micobacterias y biología molecular, dispositivos de biología médica, etc;
- herramientas de investigación clínica y desarrollo (7,8%): herramientas para descubrir fármacos y vacunas, estudiar genes, cultivar células y manipular líquidos, instrumentos para clasificar y analizar células, anticuerpos monoclonales, etc.
Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (57,4%), Europa/Oriente Medio/África (21,9%), Asia (15%) y otros (5,7%).
Número de empleados: 73 000
Ventas por actividad
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Medical
49,1
%
| 8 841 | 46,9 % | 9 502 | 49,1 % | +7,48 % |
Life Sciences
26,5
%
| 5 564 | 29,5 % | 5 133 | 26,5 % | -7,75 % |
Interventional
24,4
%
| 4 464 | 23,7 % | 4 736 | 24,4 % | +6,09 % |
Ventas por región
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
57,4
%
| 10 722 | 56,8 % | 11 113 | 57,4 % | +3,65 % |
EMEA
21,9
%
| 4 043 | 21,4 % | 4 244 | 21,9 % | +4,97 % |
Greater Asia
15,0
%
| 3 047 | 16,1 % | 2 913 | 15,0 % | -4,40 % |
Other
5,7
%
| 1 058 | 5,6 % | 1 102 | 5,7 % | +4,16 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 01/01/09 |
| Director of Finance/CFO | 52 | 06/09/21 | |
| Chief Tech/Sci/R&D Officer | 48 | 01/01/19 | |
Joseph Smith
CTO | Chief Tech/Sci/R&D Officer | - | 29/11/21 |
Denise Fleming
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/07/22 |
Ronald Silverman
CTO | Chief Tech/Sci/R&D Officer | 54 | 04/12 |
Claudia Curtis
CMP | Compliance Officer | - | 01/03/04 |
Ami Simunovich
IRO | Public Communications Contact | - | 01/01/18 |
Gregory Rodetis
IRC | Investor Relations Contact | - | 01/01/16 |
Michelle Quinn
LAW | General Counsel | 56 | 01/02/19 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 24/09/02 |
Catherine Burzik
BRD | Director/Board Member | 73 | 29/01/13 |
| Director/Board Member | 69 | 26/07/10 | |
| Director/Board Member | 59 | 10/08/18 | |
Timothy Ring
BRD | Director/Board Member | 66 | 29/12/17 |
Andy Eckert
BRD | Director/Board Member | 62 | 23/09/16 |
| Director/Board Member | 68 | 20/11/06 | |
Bill Brown
BRD | Director/Board Member | 61 | 28/02/22 |
Thomas Polen
CEO | Chief Executive Officer | 50 | 01/01/09 |
Carrie Byington
BRD | Director/Board Member | 61 | 21/10/21 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 370 594 232 | 287 994 622 ( 77,71 %) | 81 692 000 ( 22,04 %) | 77,71 % |
Información de la empresa
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Becton Dickinson India Pvt Ltd.
| |
Becton Dickinson Luxembourg Finance SARL
| |
Becton, Dickinson & Co. Master Retirement Trust
| |
Employees Retirement Plan of C.R. Bard, Inc.
 Employees Retirement Plan of C.R. Bard, Inc. Investment ManagersFinance The Employees Retirement Plan of C.R. Bard, Inc. provides retirement benefit services. The private company is located in the US. |
Investment Managers
|
Becton Dickinson Euro Finance SARL
 Becton Dickinson Euro Finance SARL Finance/Rental/LeasingFinance Part of Becton, Dickinson & Co., Becton Dickinson Euro Finance SARL is a financing subsidiary/special purpose entity. The private company is based in Luxembourg, Luxembourg. |
Finance/Rental/Leasing
|
Becton, Dickinson BV
 Becton, Dickinson BV Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Becton, Dickinson BV is a Dutch company that manufactures and wholesales medical, surgical & pharmaceutical products. The private company is based in Vianen, Netherlands. The CEO of the company is Vincent A. Forlenza. |
Medical Specialties
|
Sector
Ventas por actividad
Ventas por región
Calificación trading
Calificación Inversor
ESG Refinitiv
Venta
Compra
Recomendación promedio
COMPRAR
Numero de análisis
16
Último precio de cierre
231,6
USD
Precio objetivo promedio
279
USD
Diferencia / Objetivo Promedio
+20,48 %
Revisiones del BPA
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| -2,31 % | 187 mil M | |
| -3,20 % | 106 mil M | |
| +0,20 % | 49,45 mil M | |
| +17,29 % | 48 mil M | |
| +4,06 % | 40,84 mil M | |
| +2,07 % | 26,48 mil M | |
| +2,36 % | 26,25 mil M | |
| +12,96 % | 24,62 mil M | |
| -1,93 % | 24,52 mil M |
- Bolsa de valores
- Acciones
- Acción BDX
- Acción BDX
- Empresa Becton, Dickinson and Company
